# Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome

> **NCT05373134** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 40 (estimated)

## Conditions studied

- Hepatopulmonary Syndrome

## Interventions

- **DRUG:** Pentoxifylline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05373134
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-05
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05373134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05373134, "Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05373134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*